Generative artificial intelligence in drug discovery: basic framework, recent advances, challenges, and opportunities
There are two main ways to discover or design small drug molecules. The first involves fine-tuning existing molecules or commercially successful drugs through quantitative structure-activity relationships and virtual screening. The second approach involves generating new molecules through de novo dr...
| Príomhchruthaitheoirí: | , , , , , , |
|---|---|
| Formáid: | Alt |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
Frontiers Media S.A.
2024-02-01
|
| Sraith: | Frontiers in Pharmacology |
| Ábhair: | |
| Rochtain ar líne: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1331062/full |